XCSFDHG46767FHJHJF
tdp2664 E money daily GlaxoSmithKline plc (LON:GSK) has launched its Life Sciences Innovation Fund in Canada. GlaxoSmithKline plc (LON:GSK) Launching Canada Fund Flash Player 9 or higher is required to view the chart Click here to download Flash Player now View the full GSK chart at Wikinvest GlaxoSmithKline plc (LON:GSK) has announced the launch of the GlaxoSmithKline plc (LON:GSK) Life Sciences Innovation Fund in Canada. This $50 million fund is aimed to advance the commercialization of scientific innovation in Canada by investing in early stage breakthrough research. The fund will identify strategic investment opportunities within Canada’s life sciences industry. Paul Lucas, President and CEO, GlaxoSmithKline plc (LON:GSK), said that, “The GlaxoSmithKline plc (LON:GSK) Canada Life Sciences Innovation Fund will provide a competitive advantage to Canada’s life sciences industry and help advance the commercialization of research. This is an important step in addressing Canada’s innovation gap and we’re excited by the prospect of developing even closer ties with leading research organizations across Canada to enhance opportunities for innovation and create new high-value jobs". GlaxoSmithKline plc (LON:GSK) company shares stood at 1390.5 at the end of the last trading session (last trade 11:01). Price History Last Price: 1390.5 52 Week Range: 750.00- 1,414.50 Last Vol: 1565582 3 Month Vol: 8909620
No comments:
Post a Comment